Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23803)

• Formulation Name: Lefamulin 150 mg Injection
• Company: Nabriva Therapeutics Us

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Lefamulin	(DME6G97)	Community-acquired pneumonia	CA40.Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Kyselina citronova	(E00014)	311	Acidulant; Antioxidant; Buffering agent; Complexing agent; Flavoring agent
Sodium chloride	(E00077)	5234	Diluent; Tonicity agent
Sodium citrate dihydrate	(E00369)	71474	Alkalizing agent; Buffering agent; Complexing agent; Emulsifying agent
Water	(E00035)	962	Solvent